Last Updated:
October 27, 2021

Click here to submit your article
Posts tagged "REGRESSION"

Regression Analysis of Weekly Returns between NIFTY50 and Syngene International Ltd

Regression Analysis of  Weekly Returns between NIFTY50 and Syngene International Ltd Submitted By: Swaraj Bhattacharya Roll No. 57 ITM Executive MBA Batch 1 (2015-2017) Introduction: Syngene is a leading custom research and manufacturing organization, which supports R&D programs from lead generation to clinical supplies. This company was incorporated in 1993 as a subsidiary of Biocon Limited. Syngene has a strong corporate governance framework with a focus on client satisfaction, quality, safety, ethics and integrity. Syngene has state-of-the-art research facilities certified with ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007. Over the last 20 years, they have successfully offered there services to Read More
Views : 7211

Regression Analysis of Weekly Return between Nifty 50 and JKumar Infraprojects Limited.

Author: Janhavi Mukesh Rakhade (EMBA 17) Introduction: J kumar Infraproject Ltd earnings have grown by 10.6% whereas share price has depreciated -5.5% CAGR over the past five years. J Kumar Infraproject Ltd share price has depreciated 10.2% annually over the past ten years. Objective: To find Beta of J Kumar Infraproject Limited Views & Reviews: J Kumar Infraproject Limited having a market cap of Rs. 1,360.09 crore operating in infrastructure. Total income of Rs 823.07 crore up 70.31% from last quarter total income of Rs. 483.28 crore and up 2.64% from last year same quarter total income of Rs. 801.91 Read More
Views : 44

Regression Analysis of Weekly Returns between Nifty 50 and Glenmark

Author: Gifty k biju ( EMBA 17 ) Introduction: Glenmark Pharmaceuticals Limited is a pharmaceutical company headquartered in Mumbai, India that was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer 2. Glenmark Pharmaceuticals Ltd earnings have grown by 13.2%, whereas share price has depreciated -7% CAGR over the past five years, indicating the company’s share price is likely undervalued. 3. Glenmark Pharmaceuticals Ltd share price has depreciated 7.1% annually over the past ten years. Objective: To find Beta of Glenmark Views & Reviews: Glenmark launches SUTIB (Sunitinib) – priced 96% lower than the Read More
Views : 109

REGRESSION ANALYSIS OF WEEKLY RETURNS BETWEEN NIFTY50 AND VEDANTA LIMITED Author: Vignesh N S, Roll No. 33, ITM EMBA batch 1

REGRESSION ANALYSIS OF WEEKLY RETURNS BETWEEN NIFTY50 AND VEDANTA LIMITED Author: Vignesh N S, Roll No. 33, ITM EMBA batch 17 > Introduction • Vedanta Limited, a subsidiary of Vedanta Resources Limited, is one of the world’s leading diversified natural resource companies with business operations in India, South Africa, Namibia, and Australia. Vedanta is a leading producer of Oil & Gas, Zinc, Lead, Silver, Copper, Iron Ore, Steel, Aluminium & Power. • The company has been conferred with the CII-ITC Sustainability Award, a FICCI CSR Award, Dun & Bradstreet Awards in Metals & Mining, and The Great Place to Work Read More
Views : 70

REGRESSION ANALYSIS OF WEEKLY RETURNS BETWEEN NIFTY50 AND VEDANTA LIMITED Author: Vignesh N S, Roll No. 33, ITM EMBA batch 17

> Introduction • Vedanta Limited, a subsidiary of Vedanta Resources Limited, is one of the world’s leading diversified natural resource companies with business operations in India, South Africa, Namibia, and Australia. Vedanta is a leading producer of Oil & Gas, Zinc, Lead, Silver, Copper, Iron Ore, Steel, Aluminium & Power. • The company has been conferred with the CII-ITC Sustainability Award, a FICCI CSR Award, Dun & Bradstreet Awards in Metals & Mining, and The Great Place to Work Award. • For two decades, Vedanta has been contributing to India’s growth story. The company is among top private sector contributors Read More
Views : 57

Regression Analysis of Weekly Returns between Nifty 50 and Procter & Gamble Health Limited

Author: Pavitra Palani Anandraj ( EMBA 17 ) Introduction: 1. Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967. 2. Procter & Gamble Health Ltd earnings have grown by 32% over past 5 years. 3. Procter & Gamble Health Ltd share price has appreciated 54.2% CAGR over past 5 years. 4. Procter & Gamble Health Ltd share price has appreciated 25.4% annually over the past ten years. Objective: To find Beta of Procter & Gamble Health Limited Views & Reviews: 1. Net profit of Procter & Gamble Health Read More
Views : 115